What was the size and price of the RSU-related transaction for CapsoVision (CV)?

Henry acquired 2,022 CapsoVision shares at a reported transaction price of $7.58 per share. These shares came from the vesting and conversion of restricted stock units, not from buying shares in the open market, and reflect equity incentive compensation vesting.

CapsoVision (CV) director converts RSUs into 2,022 common shares in equity grant vesting

Q: How do King Wen-Herng Henry’s CapsoVision (CV) RSUs vest?

The RSU grant vests in two equal installments each year. According to the disclosure, 50% of the RSUs vest on June 30 of the applicable year and the remaining 50% vest on December 31, creating two vesting events tied to the original equity award.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

CapsoVision, Inc director King Wen-Herng Henry exercised restricted stock units to acquire 2,022 shares of Common Stock on June 30, 2026. The shares were acquired at a reported transaction price of $7.58 per share through the conversion of RSUs granted as equity compensation.

The RSUs were originally granted on March 19, 2026 using a fair market value of $6.18 per share and vest in two equal installments, on June 30 and December 31 of the applicable year. This transaction reflects vesting of one-half of the original RSU grant and the delivery of the underlying shares.

Following the transaction, Henry directly holds 25,619 shares of CapsoVision common stock and 2,023 RSUs, indicating remaining unvested equity from the same or other awards.

Insider Trade Summary

2,022 shares exercised/converted

Mixed 2 txns

Insider King Wen-Herng Henry

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit (RSU)	2,022	$0.00	--
Exercise	Common Stock	2,022	$7.58	$15K

Holdings After Transaction: Restricted Stock Unit (RSU) — 2,023 shares (Direct, null); Common Stock — 25,619 shares (Direct, null)

Footnotes (1)

Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. The Restricted Stock Units (RSUs), the conversion of which are reported herein, were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer on 3/19/2026 utilizing a fair market value (FMV) of a share of the issuers stock of $6.18. The RSU grant vests as to 50% of the RSUs subject to the award on June 30 of the applicable year and as to 50% of the RSUs subject to the award on December 31 of that year. This report reflects the vesting of one-half portion of the original RSU grant and the acquisition by the Reporting Person of the underlying shares.

Key Figures

Shares acquired via RSU exercise: 2,022 shares Transaction price per share: $7.58/share Common shares after transaction: 25,619 shares +3 more

6 metrics

Shares acquired via RSU exercise 2,022 shares Common Stock acquired on June 30, 2026

Transaction price per share $7.58/share Reported for Common Stock on June 30, 2026

Common shares after transaction 25,619 shares Direct holdings following June 30, 2026 transaction

RSUs remaining after transaction 2,023 RSUs Derivative holdings following June 30, 2026 conversion

RSU grant fair market value $6.18/share Fair market value used for March 19, 2026 RSU grant

RSU vesting schedule 50% June 30, 50% December 31 Annual vesting terms for the RSU grant

Key Terms

Restricted Stock Unit (RSU), equity incentive grants, fair market value (FMV), Exercise or conversion of derivative security

4 terms

Restricted Stock Unit (RSU) financial

"Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share..."

A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.

equity incentive grants financial

"granted to the Reporting Person by the issuer as part of equity incentive grants made..."

fair market value (FMV) financial

"utilizing a fair market value (FMV) of a share of the issuers stock of $6.18."

Exercise or conversion of derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 08:18 PM Accepted by SEC EDGAR 07/01/2026 - 08:18 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

King Wen-Herng Henry

(Last)

(First)

(Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA

CALIFORNIA

95070

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock⁽¹⁾	06/30/2026		M		2,022	A	$7.58	25,619	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit (RSU)	$0	06/30/2026		M			2,022	⁽²⁾	⁽²⁾	Common Stock	2,022	$0	2,023	D

Explanation of Responses:

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. The Restricted Stock Units (RSUs), the conversion of which are reported herein, were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer on 3/19/2026 utilizing a fair market value (FMV) of a share of the issuers stock of $6.18. The RSU grant vests as to 50% of the RSUs subject to the award on June 30 of the applicable year and as to 50% of the RSUs subject to the award on December 31 of that year. This report reflects the vesting of one-half portion of the original RSU grant and the acquisition by the Reporting Person of the underlying shares.

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Wen-Herng Henry King	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did CapsoVision (CV) director King Wen-Herng Henry report?

King Wen-Herng Henry reported exercising restricted stock units to acquire 2,022 CapsoVision common shares. The June 30, 2026 transaction converted RSUs into stock as part of his equity compensation, rather than an open-market purchase or sale, and increased his directly held common shares.

How many CapsoVision (CV) shares does King Wen-Herng Henry hold after this Form 4?

After the transaction, Henry holds 25,619 CapsoVision common shares directly. He also has 2,023 restricted stock units remaining, which represent additional contingent rights to receive common stock as those units vest under the original grant terms.

How do King Wen-Herng Henry’s CapsoVision (CV) RSUs vest?

The RSU grant vests in two equal installments each year. According to the disclosure, 50% of the RSUs vest on June 30 of the applicable year and the remaining 50% vest on December 31, creating two vesting events tied to the original equity award.

When were the CapsoVision (CV) RSUs granted to King Wen-Herng Henry and at what fair market value?

The RSUs were granted on March 19, 2026 using a fair market value of $6.18 per share. This fair market value was used for the equity incentive grant, and the June 30 vesting event converted a portion of those RSUs into common shares.

Is King Wen-Herng Henry’s CapsoVision (CV) Form 4 a buy or a sale of shares?

The Form 4 reflects an acquisition of shares through RSU vesting, not an open-market trade. The transaction is coded as an exercise or conversion of derivative securities, meaning it is compensation-related rather than a discretionary purchase or sale in the market.